Vertex Pharmaceuticals Incorporated (VRTX)
VRTX price $524.46 +9.81 +1.91%
- Ticker
- VRTX
- Price
- $524.46
- Change
- +9.81 +1.91%
- Market cap
- $132.93B
- P/E
- 29.71
- Forward P/E
- 28.06
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 55
Vertex Pharmaceuticals Incorporated is a leading biotechnology firm primarily focused on the discovery, advancement, and marketing of innovative treatments, particularly for cystic fibrosis (CF). The company offers a range of approved medications for CF patients, including SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO, which target specific mutations within the cystic fibrosis transmembrane conductance regulator gene…